While the full scope of the health benefits cannabidiol (CBD) and hemp oil have on various human tissues is still not properly understood, a growing body of scientific data has been amassed showing the positive impact on human health from cannabis-derived phtyonutrients, and cannabinoids in particular, from studies directly documenting anti-inflammatory and sebostatic effects (http://nnw.fm/M86rC) (reducing sebum or skin oils), to improved lipid (one of the main structural ingredient of all cells) synthesis and hair growth inhibitor negation (http://nnw.fm/TG4uq). Most CBD is non-psychoactive and therefore perfectly legal in all states as well, so long as the THC concentration of the final product is under 0.3 percent. This means that the burgeoning domestic cannabis market, which is on-track to hit upwards of $6.7 billion in sales this year alone, according to leading sector analysts ArcView Market Research, can rapidly proliferate via the “narrow end of the wedge” in states that have yet to roll back prohibition on marijuana.
Rich in organic omega-6 and omega-3 essential fatty acids (which are sorely lacking in most people’s diets), as well as healthy, natural antioxidants and anti-inflammatories – hemp oils and concentrated CBDs in particular are like superfoods for bodily tissues, though the true scope of potential benefits is still a subject of increasingly intense research. The human endocannabinoid receptor system is extremely complex and still represents a vast, undiscovered country. However, we do know these receptors (the ones we have discovered, CB1 and CB2, though there may be others we have not discovered) are all over the body, throughout all major tissue systems, and that they can impact everything from homeostasis and mood, to neurological system stabilization, and even inducing/promoting cell apoptosis (internally programmed, triggered process of cell death) in numerous types of cancers.
One of the most attractive vectors here is skin-care, because these oils lends themselves so readily to being developed into and used in topical applications. Skin-care is also attractive because the skin is the largest organ of the body and the global market for skincare is upwards of $121 billion a year, according to MarketResearch.com (http://nnw.fm/li4J6), dwarfing the as-yet nascent cannabis market.
One of the more interesting plays on this vector in the space today is network marketing company, Laguna Blends, Inc. (CSE: LAG) (FSE: LB6A.F) (OTC: LAGBF), which has already planted its flag in the most lucrative niche of the cannabis market so far: edibles. Many readers may already know about Laguna Blends from products such as its flagship beverage, the hemp-infused protein coffee Caffé, which is packed with high quality whey protein, and delivers a whopping two grams of protein in every serving. Or perhaps readers have tried one of the many delicious flavors of the company’s functional beverage, Pro369 – an infused, plant-based, single serving “on-the-go” product in the same vein as the 5-hour Energy drink, but packed with HempOmega®, hemp protein, and ginseng.
The company’s move to secure a definitive agreement with and acquire the exclusive license brand name for revolutionary Swiss developer CannaCeuticals’ line of CBD skincare products is a bold move in the right direction, and one which dovetails superbly well with the company’s Affiliate Marketing Program that lets entrepreneurs start their own businesses. Laguna Blends’ proprietary, immersive networking/training platform and its affiliate marketing approach deserves closer examination by interested investors, as it speaks volumes about LAGBF’s momentum potential. However, the CannaCeuticals skincare products could be the company’s core driver moving forward, and thus deserve immediate discussion.
Shares of LAGBF jumped nicely on the recent news that clinical, independent third party testing by BioScreen Testing Services, an FDA-approved lab in the U.S., returned impressive efficacy results, including an astounding 100 percent endpoint in subjects reporting improvement to the appearance of skin within just 14 days of starting to use Canna’s CBD face serum. InvestmentPitch Media even took a closer look at the story (http://nnw.fm/rxR9p), bolstering an already prominent media presence enjoyed by Laguna Blends. CannaCeutical’s specially formulated CBD7 skincare products, using Swiss-acquired CBD, also contain proprietary micro-encapsulated time-release spheres. Similar microspheres are now common in many cosmetics or skincare products and have become an accepted standard method of delivery for time-release ingredients. Here, such microspheres actively shield the rich, organic CBD from oxidation, while simultaneously allowing the product to continue releasing bursts of anti-aging ingredients, even long after the product has been applied to the skin.
CannaCeuticals prides itself on using only the purest cosmeceutical-grade, THC-free CBD, as well. This CBD is always non-toxic and non-GMO. This ironclad commitment to product quality really underscores the antioxidant, anti-aging and anti-inflammatory capabilities of its CBD7 skincare products, and provides LAGBF with an easily marketable and unimpeachable product pedigree. This is the stuff brand recognition is made of and if extant user receptivity is any indication – with sales for the 11-week period ended May 31 totaling $105,000 (unaudited), handily beating internal projections – Laguna Blends could be one of the booming cannabis sector’s brightest rising stars.
For more information, visit www.lagunablends.com
Let us hear your thoughts: Laguna Blends, Inc. Message Board